Recent Quotes (30 days)

You have no recent quotes
chg | %

Microbix Biosystems Inc  

(Public, TSE:MBX)   Watch this stock  
Find more results for MBX
-0.005 (-2.38%)
Dec 9 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.20 - 0.21
52 week 0.18 - 0.35
Open 0.21
Vol / Avg. 69,500.00/42,050.00
Mkt cap 16.21M
P/E 45.15
Div/yield     -
EPS 0.00
Shares 84.70M
Beta -1.13
Inst. own     -
Feb 14, 2017
Q1 2017 Microbix Biosystems Inc Earnings Release (Estimated) Add to calendar
Oct 19, 2016
Q4 2016 Microbix Biosystems Inc Earnings Release

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 2.13% 6.92%
Operating margin -6.26% 3.93%
EBITD margin - 15.77%
Return on average assets 0.78% 2.96%
Return on average equity 1.35% 5.22%
Employees 20 -
CDP Score - -


265 Watline Ave
+1-905-3618910 (Phone)
+1-905-3618911 (Fax)

Website links


Microbix Biosystems Inc. is a Canada-based life science company. The Company is a manufacturer of viral and bacterial antigens and reagents for the diagnostics industry. The Company's segments include Virology Products and Technologies, Lumisort and Kinlytic. It is engaged in Virology Products business, which includes the manufacture and sale of cell culture-based biological products. It specializes in the research and development of biological solutions, including products for human health applications, primarily in the vaccine and therapeutic markets, as well as animal reproductive markets. It is also engaged in developing VIRUSMAX, which is a virus yield enhancement technology used to increase influenza vaccine manufacturing yields, and Kinlytic, a thrombolytic drug used to treat blood clots. It is involved in developing LumiSort, a semen sexing technology used in livestock industries. It owns and operates a virology manufacturing facility in Mississauga, Ontario.

Officers and directors

William J. Gastle Executive Chairman of the Board
Vaughn C. Embro-Pantalony President, Chief Executive Officer, Director
Jim Currie Chief Financial Officer
Age: 58
Charles S. Wallace Chief Financial Officer
Peter M. Blecher Independent Director
Mark A. Cochran Independent Director
Cameron L Groome Independent Director
Martin A. Marino Independent Director
Joseph D. Renner Independent Director